Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2020 ,inter alia, to consider and approve updated Audited Financial Results for the quarter and financial year ended 31.03.2019. The Stock Exchange is aware that Parabolic Drugs Limited is under Corporate Insolvency Resolution Process and in terms of the order of the Hon'ble NCLT dated August 30, 2018, the powers of the Board of Directors are suspended and are vested in the Resolution Professional, business and assets are being managed by the Resolution Professional. The Resolution Professional is performing the functions as mentioned under Insolvency and Bankruptcy Code (the Code). In view of the above and pursuant to Regulation 29 of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that updated Audited Financial Results for the quarter and financial year ended 31.03.2019 will be considered and disseminated on 24th August, 2020. This is for information and records.